More on APRE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.62 |
|
|||
| Open | $0.66 | ||||
| 52 Wk High | $0.08 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $0.66 | ||||
| Day Low | $0.57 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 160,105 | ||||
- Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology
- Ladenburg Thalmann Starts Aprea (APRE) at Buy
- Aprea Therapeutics to Present at October Conferences
- Aprea to present Phase 1 data on APR-1051 at EORTC-NCI-AACR symposium
- Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
- Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
- Form 8-K Aprea Therapeutics, Inc. For: Aug 28
- Aprea Therapeutics updates patent portfolio to 28 issued patents
- Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
- Form SCHEDULE 13G/A Aprea Therapeutics, Inc. Filed by: LYTTON LAURENCE W
Entities mentioned with APRE
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maxim Group | View Related Stories »
- Show More...
